ArticleMolecular and clinical oncology2017

Response to regorafenib at an initial dose of 120 mg as salvage therapy for metastatic colorectal cancer.

Hiroshi OsawaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.